About: Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) articolo scientifico (pubblicato il 1996) (it) наукова стаття, опублікована в січні 1996 (uk) im Januar 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1996 (ast) artikull shkencor i botuar më 01 janar 1996 (sq) scientific article published on 01 January 1996 (en)
publication date	wds:Q71119730-1E3CF376-EBC4-4716-AAEF-A0758398D6AF
publication date	1996-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71119730-821669A8-D06E-41F2-9522-EBEBB9E737EB
language of work or name	English
author name string	wds:Q71119730-606714A3-3AA5-42C0-A6BC-801E269C63E0 wds:Q71119730-6E134DA1-5578-409E-A836-FF59E08BFBA3 wds:Q71119730-9CA04C71-3F0A-4158-8AA7-28CC6775C919
author name string	M A Visalli M R Jacobs P C Appelbaum
rdfs:label	Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (en) Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (nl) Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (sq)
skos:prefLabel	Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (en) Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (nl) Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (sq)
name	Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (en) Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (nl) Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (sq)
title	wds:Q71119730-676EB572-1295-4EDA-96B9-CDA106CCAC8D
title	Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology (en)
page(s)	wds:Q71119730-6A6DF951-814D-4678-85F3-B3AC9B529275
page(s)	77-84
instance of	wds:Q71119730-0965B68A-D8B6-4EC4-9A4E-49E8C987F11C
instance of	scholarly article
PubMed ID	wds:Q71119730-57A8F2C6-A2D2-469A-8073-650F3DFE6C28
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8647777
PubMed ID	8647777
published in	wds:Q71119730-A11EBDF0-1DAF-4707-A664-743542AD2FD9
published in	Journal of Antimicrobial Chemotherapy
issue	wds:Q71119730-C677409C-CC23-457C-82FD-0C2DE295163B
volume	wds:Q71119730-3E2C98B4-D535-4A5D-A6BB-5D11EB215EB9
issue	1
volume	37
number of pages	wds:Q71119730-D198792E-F101-47A4-BA9E-480D8BBD1E7F
number of pages	8 (xsd:decimal)
DOI	wds:Q71119730-2BBA7C84-3777-4FF1-A2C6-14AD12389216
DOI	http://dx.doi.org/10.1093/JAC/37.1.77
DOI	10.1093/JAC/37.1.77
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71119730
is cites work of	Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Trovafloxacin: a new fluoroquinolone Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by Etest Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model Fluoroquinolones Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique Acute bacterial meningitis Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus. Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically ac
is cites work of	wds:Q39475998-AB6A0DC5-5AF3-471D-B6B6-241AAA2947F5 wds:Q37879173-684C551A-14EF-414B-B969-AD28FB014E56 wds:Q73829736-BCF10366-B9B4-4E17-8490-E9E048F011A4 wds:Q33977786-C65C1557-A2BB-4CD3-9FC7-A1A797D9D1BE wds:Q35133005-DBC6E2C8-8AEB-4F8E-9D2A-AB3C10312B72 wds:Q74512124-859E015A-1BCA-478F-B431-3AAC6CBF943A wds:Q33979388-CC00CFA3-B207-4320-86D7-7F41CCC6DD03 wds:Q39471404-77CFE4AB-7D69-4859-9DB8-E02DBEDB1019 wds:Q54085337-CF281BDB-AC77-4ADB-9446-F92A2561A5CD wds:Q28368317-9EEC2004-610C-4EE7-8FF2-F8DE632C2C1C wds:Q33692694-449D71E6-E1D9-4187-A921-774094FAE77F wds:Q71869447-FAD642B0-1831-4E9F-9834-E1D7D7D7E042 wds:Q33695030-29648D4D-B654-4FD5-A8D9-F1F48D25C489 wds:Q37064474-BC7B64E3-B587-47F0-AEC7-D5A6E23B74A4 wds:Q24673222-BDDC6D51-3806-4159-AE10-F18D95F62AC3 wds:Q39557796-D28DEA82-45C5-4BC9-84F9-9E33D219BBA1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software